Another Biosimilar for a Common Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved another biosimilar for a common breast cancer medication.
Colorectal Cancer FAQs
There will be 101,000 new cases of colon cancer and over 44,000 new cases of rectal cancer in the United States this year, the American Cancer Society (ACS) estimates. Here's what you need to know.
Company Under Fire for Illegal Screening Tool
Total Thermal Imaging, Inc., is in the hot seat for marketing and selling an unapproved product for detecting certain diseases.
Heated Tobacco Devices: Not a Safe Option
New heated tobacco devices are not a safe alternative to smoking traditional cigarettes or using electronic cigarettes, according to a new study.
Reducing Women's Cancer Risk
Everyday choices can play a significant role in your risk of cancer, regardless of your gender. Here are some specific steps women can take to reduce their cancer risk.
Cancer Symptoms Men Might Miss
Cancer can affect anyone, and that includes men. Below, we discuss seven cancer symptoms that men may overlook.
A New Biosimilar for a Breast Cancer Rx
The US Food and Drug Administration (FDA) has approved the third Herceptin (trastuzumab) biosimilar to treat certain types of cancer.
The Importance of Cancer Screenings
Skipping recommended cancer screenings could put you at risk of fatal health problems, according to a new study.
'Movember' Shines Spotlight on Men's Health
It's not just about letting your facial hair grow wild — "Movember" is about men's health, and that includes suicide, prostate cancer and testicular cancer.
For National Mammography Day, we're debunking four common mammogram myths.